WHAT IS HEART FAILURE?
Heart failure is a progressive and disabling condition in which the muscle wall of the heart slowly weakens, enlarging it and preventing adequate blood pumping. “Consequently, patients suffer from breathing problems, fatigue, fluid accumulation in the lungs, and swelling of the lower limbs, and when they decompensate, they need to be hospitalized urgently for proper treatment,” he stressed.
HOW IMPORTANT IS HEART FAILURE?
In Mexico, heart failure is a condition that affects 2% of the adult population. Mexico is one of the countries in Latin America that spends the most on heart disease with 6,100 million dollars annually
The clinic’s comprehensive care model seeks to reduce hospitalizations and substantially improve the quality of life of patients with this condition.
It is the first Clinic in Latin America developed in collaboration with the companies: Novartis and Medtronic.
Heart failure is a public health problem, which is why it is increasingly important to treat the disease promptly through multidisciplinary treatment, as studies indicate that half of patients with heart failure will die within 5 years. to diagnosis.
Heart failure is a picture shared by many heart pathologies such as hypertension, coronary disease (heart attack and angina pectoris), heart valve diseases, congenital heart disease, heart damage from chemotherapy or drugs.
Queretaro, Qro. March 8, 2018.- The Instituto de Corazón de Querétaro presented an innovative model for specialized care for heart failure, whose objective is to improve the diagnosis and treatment of this condition and, with it, the quality and life expectancy of patients. patients.
Dr. Eliodoro Castro Montes, founding member of the Querétaro Heart Institute and professor at the UAQ School of Medicine, pointed out at a press conference that heart failure is characterized by increasing difficulty in pumping oxygenated blood to the organs. “Consequently, patients suffer from breathing problems, fatigue, fluid accumulation in the lungs, and swelling of the lower limbs, and when they decompensate, they need to be hospitalized urgently for proper treatment,” he stressed.
It is estimated that 2 out of every 100 adults in the world (3) ,(4) suffer from this condition which, as it worsens with age, generates enormous hospital costs and high mortality. In fact, in Latin America 6.5 million people live with this condition1, whose financial cost in the region reaches 10.7 billion dollars(5).
In Mexico, heart failure affects 2% of the adult population(6). Mexico is one of the Latin American countries that spends the most on heart disease with 6.1 billion dollars a year(7). The total cost of heart failure for the Health System was 481 million dollars in 2015(8).
Heart failure is a public health problem, which is why it is increasingly important to treat the disease promptly through multidisciplinary treatment, as studies indicate that half of patients with heart failure will die within 5 years. at diagnosis(9). In fact, this condition is a picture shared by many heart diseases such as hypertension, coronary disease (heart attack and angina), heart valve diseases, congenital heart disease, heart damage from chemotherapy or drugs.
1. Estudio “La Carga Económica de las Enfermedades Cardiacas en México” 2016
2. Estudio “The Economic Burden of Heart conditions in Latin America” 2016
3. McMurray et al. Eur Heart J 2012 ; 33 :1787-847
4. Mosterd& Hoes. Heart 2007; 93:1137-46
5. Estudio “The Economic Burden of Heart Failure in Latin America” 2016
6. Estudio “La Carga Económica de las Enfermedades Cardiacas en México” 2016
7. Estudio “The Economic Burden of Heart conditions in Latin America” 2016
8. Estudio “Carga de las enfermedades del corazón en México”, 2016
9. Roger VL, Weston SA, Redfiel MM, et. Al. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004; 291(3):344-350
In Mexico, cardiovascular diseases such as myocardial infarction, angina pectoris (ischemic heart disease) or complications of systemic arterial hypertension have been the main cause of death and disability for more than a decade, and heart failure, present in most of these conditions. , is one of the main causes of hospitalization in people over 65 years of age and one of the 10 leading causes of death and disability in the world.
Heart failure occurs when the heart muscle does not pump blood as well as it should. Certain conditions, such as narrowed arteries in the heart (coronary artery disease) or high blood pressure, progressively leave the heart too weak or stiff to fill and pump effectively. Typical symptoms are shortness of breath, swelling in the extremities, and fatigue.
Some people are more prone to heart failure than others. Sometimes it cannot be predicted, but there are known risk factors.
Risk factors include the following:
Symptoms
The symptoms that affect a person with heart failure may not always be obvious. For example, some people in the early stages may not have symptoms. On the other hand, in the most obvious cases, some of the following symptoms may occur:
Heart failure currently affects 2% of the adult population in Mexico(1), it is one of the Latin American countries that spends the most on heart disease with 6.1 billion dollars a year(2) . The total cost of heart failure for the Health System was 481 million dollars in 2015 (3).
1.Estudio de la carga de la enfermedad por condiciones cardíacas-México, pág. 20
2. Estudio “The Economic Burden of Heart conditions in Latin America”, 2016
3. Estudio “Carga de las enfermedades del corazón en México”, 2016
WHAT OBJECTIVES DOES THE HEART FAILURE CLINIC HAVE?
The heart failure clinic presented by the Instituto de Corazón de Querétaro will comprehensively care for the patient, through optimal therapies, education, a multidisciplinary medical team and the use of technologies, with a 3-month program.
The model integrates a first-rate medical team, state-of-the-art technology and protocols with the highest international standard, thanks to which it is possible to reduce hospital readmissions, emergency visits and hospitalization time; which translates into patients with a better quality of physical and emotional life.”
Privada Ignacio Zaragoza PTE # 16 II A Col. Centro.
Querétaro, Qro.
(442) 216 2745 y 46
(442) 242 5068
(442) 242-64-35
Instituto de Corazón de Querétaro 2018.
Instituto de Corazón de Querétaro 2018.